Ustekinumab Injection Suppliers & Bulk Manufacturers
Available Forms: SQ and IV injection
Available Strengths: SQ:: 45 mg, 90 mg; IV: 130 mg/vial
Reference Brands: Stelara(US)
Category: Immune Disorder
Ustekinumab injection as 45 mg and 90 mg subcutaneous syringes and a 130 mg intravenous vial. An anti-IL-12/23 biologic listed for hospitals, specialist distributors and licensed importers with cold-chain capability.
Manufacture or export Ustekinumab Injection? List it or send an offer →
Product Description:
Ustekinumab is a fully human IgG1 monoclonal antibody. It binds the p40 subunit that interleukin-12 and interleukin-23 share, so neither cytokine can signal through its receptor. This page covers both presentations. The subcutaneous 45 mg and 90 mg prefilled syringes are used for maintenance, often given by the patient or a nurse at home. The intravenous 130 mg vial, at 5 mg/mL, is used once as a weight-based induction infusion in inflammatory bowel disease.
Ustekinumab is approved for moderate to severe plaque psoriasis, psoriatic arthritis, Crohn's disease and ulcerative colitis. In psoriasis, dosing is subcutaneous throughout: 45 mg, or 90 mg in heavier patients, at weeks 0 and 4, then every 12 weeks. In Crohn's disease and ulcerative colitis, one IV infusion, diluted in sodium chloride 0.9% and run over at least an hour, is followed by subcutaneous 90 mg maintenance. Tuberculosis screening comes first. Serious infection is the main precaution, and live vaccines are avoided during treatment.
Sourcing notes. This is a biologic and a true cold-chain product. Syringes and vials are stored at 2-8 °C, never frozen, in the carton to protect them from light. Ask for temperature-logged shipping in validated packaging and a written excursion policy. Registration follows the biologics pathway with a full CTD quality file, so check whether your market expects the reference product or accepts a biosimilar. Request the batch CoA, GMP certificate, CoPP and, where national rules require it, lot release evidence. State presentation, quantity, remaining shelf life on arrival and your biologics import licence.
Ustekinumab Injection — third party manufacturing & bulk supply
Ustekinumab Injection is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:
Indicative minimum order quantity
Ustekinumab Injection is supplied as SQ and IV injection — supplied in more than one dosage form, each with its own manufacturing economics, so the indicative MOQ is a minimum order value of USD 5,000 per product. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.
Manufacturers of Ustekinumab Injection listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.
Request a quote for Ustekinumab Injection →Usually answered within 48 hours, with matched manufacturers, indicative prices and document status.
Frequently Asked Questions
Related Products
Everolimus Tablets
Strength:
0.75 mg, 1.25 mg, 2.5 mg, 5 mg, 7.5 mg, 10 mg
Form: Tablet
Reference Brands: Zortress, Afinitor(US & EU)
View DetailsSirolimus Tablet
Strength:
1 mg, 2 mg, 3 mg, 5 mg tablets
Form: Tablet
Reference Brands: Rapamune(US)
View DetailsAnakinra Injection
Strength:
100 mg/mL
Form: Injection(SQ)
Reference Brands: Kineret (US)
View DetailsCyclosporine Capsules
Strength:
25 mg, 50 mg, 100 mg
Form: Capsules
Reference Brands: Neoral, Sandimmune (US)
View DetailsFostamatinib Disodium
Strength:
100 mg, 150 mg
Form: Tablets
Reference Brands: Tavalisse (USA)
View DetailsUsually answered within 48 hours | GMP documents shared before you commit